CLINICAL_TRIALS trial_result · 2020-10-19

Clinical Trial Update: A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma [Phase 2]

Phase 2 study in participants with relapsed cutaneous T-cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Cutaneous T-Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19